Gyre Therapeutics, Inc. GYRE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s accounts payable?
- Gyre Therapeutics, Inc. (GYRE) reported accounts payable of $265K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s accounts payable changed year-over-year?
- Gyre Therapeutics, Inc.'s accounts payable increased by 117.2% year-over-year, from $122K to $265K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s accounts payable has grown at a -53.9% compound annual growth rate (CAGR), from $5.93M to $124K.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.